The DOI matches its Crossref record; 213 of the 213 references it cites were found in a registry or an index.
Imaging the evolution and pathophysiology of Alzheimer disease
Open accessAbstract
Technologies for imaging the pathophysiology of Alzheimer disease (AD) now permit studies of the relationships between the two major proteins deposited in this disease - amyloid-β (Aβ) and tau - and their effects on measures of neurodegeneration and cognition in humans. Deposition of Aβ in the medial parietal cortex appears to be the first stage in the development of AD, although tau aggregates in the medial temporal lobe (MTL) precede Aβ deposition in cognitively healthy older people. Whether aggregation of tau in the MTL is the first stage in AD or a fairly benign phenomenon that may be transformed and spread in the presence of Aβ is a major unresolved question. Despite a strong link between Aβ and tau, the relationship between Aβ and neurodegeneration is weak; rather, it is tau that is associated with brain atrophy and hypometabolism, which, in turn, are related to cognition. Although there is support for an interaction between Aβ and tau resulting in neurodegeneration that leads to dementia, the unknown nature of this interaction, the strikingly different patterns of brain Aβ and tau deposition and the appearance of neurodegeneration in the absence of Aβ and tau are challenges to this model that ultimately must be explained.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These and other studies 13,24,133,134 strongly support the concept of AD as being an amyloid-provoked, or facilitated, tauopathy, although there is also evidence that both pathologies act in synergy 135 .”
From The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics (2022) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Sleep Drives Metabolite Clearance from the Adult Brain
Xie, L., Kang, H., Xu, Q., Chen, M. J., Liao, Y., Thiyagarajan, M., O’Donnell, J., Christensen, D. J., Nicholson, C., Iliff, J. J., et al. (2013) · Science · doi:10.1126/science.1241224 · Cited by 5,411
Classification of primary progressive aphasia and its variants
Gorno-Tempini, M. L., Hillis, A. E., Weintraub, S., Kertesz, A., Mendez, M., Cappa, S. F., Ogar, J. M., Rohrer, J. D., Black, S., Boeve, B. F., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31821103e6 · Cited by 5,141
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Self-citationWhat is cognitive reserve? Theory and research application of the reserve concept
STERN, Y. (2002) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617702813248 · Cited by 3,951
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Cited by
Sorted by citations
Hallmarks of neurodegenerative diseases
Wilson, D. M., Cookson, M. R., Van Den Bosch, L., Zetterberg, H., Holtzman, D. M., & Dewachter, I. (2023) · Cell · doi:10.1016/j.cell.2022.12.032 · Cited by 1,789
Synergy between amyloid-β and tau in Alzheimer’s disease
Busche, M. A., & Hyman, B. T. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0687-6 · Cited by 1,242
López, J. A., González, H. M., & Léger, G. C. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-12-804766-8.00013-3 · Cited by 884
The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics
Karran, E., & De Strooper, B. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00391-w · Cited by 742
The Role of NMDA Receptors in Alzheimer’s Disease
Liu, J., Chang, L., Song, Y., Li, H., & Wu, Y. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00043 · Cited by 535
The multiplex model of the genetics of Alzheimer's disease
Sims, R., Hill, M., & Williams, J. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0599-5 · Cited by 466
Antibiotics, gut microbiota, and Alzheimer’s disease
Angelucci, F., Cechova, K., Amlerova, J., & Hort, J. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1494-4 · Cited by 454
Inflammatory Processes in Alzheimer’s Disease—Pathomechanism, Diagnosis and Treatment: A Review
Twarowski, B., & Herbet, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076518 · Cited by 480
The complexity of Alzheimer’s disease: an evolving puzzle
Ferrari, C., & Sorbi, S. (2021) · Physiological Reviews · doi:10.1152/physrev.00015.2020 · Cited by 343
Biomarker modeling of Alzheimer’s disease using PET-based Braak staging
Therriault, J., Pascoal, T. A., Lussier, F. Z., Tissot, C., Chamoun, M., Bezgin, G., Servaes, S., Benedet, A. L., Ashton, N. J., Karikari, T. K., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00204-0 · Cited by 308
van Oostveen, W. M., & de Lange, E. C. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042110 · Cited by 297
The human connectome in Alzheimer disease — relationship to biomarkers and genetics
Yu, M., Sporns, O., & Saykin, A. J. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00529-1 · Cited by 265
Association of Apolipoprotein E ε4 With Medial Temporal Tau Independent of Amyloid-β
Therriault, J., Benedet, A. L., Pascoal, T. A., Mathotaarachchi, S., Chamoun, M., Savard, M., Thomas, E., Kang, M. S., Lussier, F., Tissot, C., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2019.4421 · Cited by 256
Sleep as a Potential Biomarker of Tau and β-Amyloid Burden in the Human Brain
Winer, J. R., Mander, B. A., Helfrich, R. F., Maaß, A., Harrison, T. M., Baker, S. L., Knight, R. T., Jagust, W. J., & Walker, M. P. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0503-19.2019 · Cited by 259
Self-citation18F-MK-6240 PET for early and late detection of neurofibrillary tangles
Pascoal, T. A., Therriault, J., Benedet, A. L., Savard, M., Lussier, F. Z., Chamoun, M., Tissot, C., Qureshi, M. N. I., Kang, M. S., Mathotaarachchi, S. S., et al. (2020) · Brain · doi:10.1093/brain/awaa180 · Cited by 263
Association of Short and Long Sleep Duration With Amyloid-β Burden and Cognition in Aging
Winer, J. R., Deters, K., Kennedy, G., Jin, M., Goldstein‐Piekarski, A. N., Poston, K. L., & Mormino, E. C. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2021.2876 · Cited by 249
Rostral locus coeruleus integrity is associated with better memory performance in older adults
Dahl, M. J., Mather, M., Düzel, S., Bodammer, N., Lindenberger, U., Kühn, S., & Werkle‐Bergner, M. (2019) · Nature Human Behaviour · doi:10.1038/s41562-019-0715-2 · Cited by 228
Younan, D., Petkus, A. J., Widaman, K. F., Wang, X., Casanova, R., Espeland, M. A., Gatz, M., Henderson, V. W., Manson, J. E., Rapp, S. R., et al. (2019) · Brain · doi:10.1093/brain/awz348 · Cited by 209
Sleep Disturbance Forecasts β-Amyloid Accumulation across Subsequent Years
Winer, J. R., Mander, B. A., Kumar, S., Reed, M., Baker, S. L., Jagust, W. J., & Walker, M. P. (2020) · Current Biology · doi:10.1016/j.cub.2020.08.017 · Cited by 215
Self-citationUpdates in Alzheimer's disease: from basic research to diagnosis and therapies
Liu, E., Zhang, Y., & Wang, J. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00432-x · Cited by 241
Zhang, X., Wang, R., Hu, D., Sun, X., Fujioka, H., Lundberg, K., Chan, E. R., Wang, Q., Xu, R., Flanagan, M. E., et al. (2020) · Science Advances · doi:10.1126/sciadv.abb8680 · Cited by 200
Biomarker-based staging of Alzheimer disease: rationale and clinical applications
Therriault, J., Schindler, S. E., Salvadó, G., Pascoal, T. A., Benedet, A. L., Ashton, N. J., Karikari, T. K., Apostolova, L. G., Murray, M. E., Verberk, I. M. W., et al. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-00942-2 · Cited by 225
Microglial activation and tau burden predict cognitive decline in Alzheimer’s disease
Malpetti, M., Kievit, R. A., Passamonti, L., Jones, P. S., Tsvetanov, K. A., Rittman, T., Mak, E., Nicastro, N., Bevan-Jones, W. R., Su, L., et al. (2020) · Brain · doi:10.1093/brain/awaa088 · Cited by 194
Regional Aβ-tau interactions promote onset and acceleration of Alzheimer’s disease tau spreading
Lee, W. J., Brown, J. A., Kim, H. R., Joie, R. L., Cho, H., Lyoo, C. H., Rabinovici, G. D., Seong, J., & Seeley, W. W. (2022) · Neuron · doi:10.1016/j.neuron.2022.03.034 · Cited by 198
Duara, R., & Barker, W. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01185-z · Cited by 187
Novel Therapeutic Approaches for Alzheimer’s Disease: An Updated Review
Yu, T.-W., Lane, H., & Lin, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158208 · Cited by 190
Molecular Mechanisms of Neuroinflammation in Aging and Alzheimer’s Disease Progression
Andronie-Cioară, F. L., Ardelean, A. I., Nistor-Cseppento, C. D., Jurcău, A., Jurcău, M. C., Pașcalău, N., & Marcu, F. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031869 · Cited by 170
Wang, P., Yu, L., Gong, J., Xiong, J., Zi, S., Xie, H., Zhang, F., Mao, Z., Liu, Z., & Kim, J. S. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202206894 · Cited by 163
Han, F., Chen, J., Belkin-Rosen, A., Gu, Y., Luo, L., Buxton, O. M., Liu, X., & Initiative, A. D. N. (2021) · PLoS Biology · doi:10.1371/journal.pbio.3001233 · Cited by 170
Cortical tau deposition follows patterns of entorhinal functional connectivity in aging
Adams, J. N., Maass, A., Harrison, T. M., Baker, S. L., & Jagust, W. J. (2019) · eLife · doi:10.7554/elife.49132 · Cited by 160
Self-citationRoe, J. M., Dídac Vidal-piñeiro, A., Sørensen, Ø., Brandmaier, A. M., Düzel, S., Gonzalez, H. A., Kievit, R., Knights, E., Kühn, S., Lindenberger, U., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21057-y · Cited by 159
Dahl, M. J., Mather, M., Werkle‐Bergner, M., Kennedy, B. L., Guzman, S. J., Hurth, K. M., Miller, C. A., Qiao, Y., Shi, Y., Chui, H. C., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.11.006 · Cited by 149
Role of natural products for the treatment of Alzheimer’s disease
Noori, T., Dehpour, A. R., Sureda, A., Sobarzo-Sanchez, E., & Shirooie, S. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173974 · Cited by 141
MicroRNAs in Alzheimer’s Disease: Diagnostic Markers or Therapeutic Agents?
Angelucci, F., Čechová, K., Vališ, M., Kuča, K., Zhang, B., & Hort, J. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00665 · Cited by 145
Alzheimer’s Disease Detection Using Deep Learning on Neuroimaging: A Systematic Review
Alsubaie, M. G., Luo, S., & Shaukat, K. (2024) · Machine Learning and Knowledge Extraction · doi:10.3390/make6010024 · Cited by 156
Giorgio, J., Adams, J. N., Maass, A., Jagust, W. J., & Breakspear, M. (2024) · Neuron · doi:10.1016/j.neuron.2023.11.014 · Cited by 133
Self-citationCai, L., Yang, C., Jia, W., Liu, Y., Xie, R., Lei, T., Yang, Z., He, X., Tong, R., & Gao, H. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201909999 · Cited by 133
The human olfactory system in two proteinopathies: Alzheimer’s and Parkinson’s diseases
Úbeda‐Bañón, I., Saiz‐Sánchez, D., Flores‐Cuadrado, A., Corroto, E. R., González-Rodríguez, M., Villar‐Conde, S., Astillero‐Lopez, V., Cabello, J. P., Gallardo‐Alcañiz, M. J., Vaamonde‐Gamo, J., et al. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00200-7 · Cited by 131
Temporal Dynamics of β-Amyloid Accumulation in Aging and Alzheimer Disease
Jagust, W. J., Landau, S. M., & Jack, C. R. (2021) · Neurology · doi:10.1212/wnl.0000000000011524 · Cited by 125
Self-citationMuch More Than a Scaffold: Cytoskeletal Proteins in Neurological Disorders
Muñoz-Lasso, D. C., Mateo, C. R., Pallardó, F. V., & González‐Cabo, P. (2020) · Cells · doi:10.3390/cells9020358 · Cited by 129
Modulating Gamma Oscillations Promotes Brain Connectivity to Improve Cognitive Impairment
Liu, C., Han, T., Xu, Z., Liu, J., Zhang, M., Du, J., Zhou, Q., Duan, Y., Li, Y., Wang, J., et al. (2021) · Cerebral Cortex · doi:10.1093/cercor/bhab371 · Cited by 129
Kazim, S. F., Seo, J. H., Bianchi, R., Larson, C. S., Sharma, A., Wong, R. K. S., Gorbachev, K., & Pereira, A. C. (2021) · eNeuro · doi:10.1523/eneuro.0418-20.2020 · Cited by 120
Timing of lifespan influences on brain and cognition
Walhovd, K. B., Lövden, M., & Fjell, A. M. (2023) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2023.07.001 · Cited by 112
Autophagy Activator Drugs: A New Opportunity in Neuroprotection from Misfolded Protein Toxicity
Thellung, S., Corsaro, A., Nizzari, M., Barbieri, F., & Florio, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040901 · Cited by 118
Unmasking selective path integration deficits in Alzheimer’s disease risk carriers
Bierbrauer, A., Kunz, L., Gomes, C. A., Luhmann, M., Deuker, L., Getzmann, S., Wascher, E., Gajewski, P. D., Hengstler, J. G., Fernandez-Alvarez, M., et al. (2020) · Science Advances · doi:10.1126/sciadv.aba1394 · Cited by 125
Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages
Pascoal, T. A., Benedet, A. L., Tudorascu, D., Therriault, J., Mathotaarachchi, S. S., Savard, M., Lussier, F. Z., Tissot, C., Chamoun, M., Kang, M. S., et al. (2021) · Brain · doi:10.1093/brain/awab248 · Cited by 122
An Activatable NIR‐II Fluorescent Reporter for In Vivo Imaging of Amyloid‐β Plaques
Miao, J., Miao, M., Jiang, Y., Zhao, M., Li, Q., Zhang, Y., An, Y., Pu, K., & Miao, Q. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202216351 · Cited by 119
Human lifespan changes in the brain’s functional connectome
Sun, L., Zhao, T., Liang, X., Xia, M., Li, Q., Liao, X., Gong, G., Wang, Q., Pang, C., Yu, Q., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-01907-4 · Cited by 132
Self-citationAlzheimer's disease detection from structural MRI using conditional deep triplet network
Orouskhani, M., Zhu, C., Rostamian, S., Zadeh, F. S., Shafiei, M., & Orouskhani, Y. (2022) · Neuroscience Informatics · doi:10.1016/j.neuri.2022.100066 · Cited by 115
Staging of Alzheimer’s disease: past, present, and future perspectives
Therriault, J., Zimmer, E. R., Benedet, A. L., Pascoal, T. A., Gauthier, S. G., & Rosa‐Neto, P. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.05.008 · Cited by 123
Tau deposition is associated with functional isolation of the hippocampus in aging
Harrison, T. M., Maaß, A., Adams, J. N., Du, R., Baker, S. L., & Jagust, W. J. (2019) · Nature Communications · doi:10.1038/s41467-019-12921-z · Cited by 113
Self-citationRanasinghe, K. G., Cha, J., Iaccarino, L., Hinkley, L. B. N., Beagle, A. J., Pham, J. Q., Jagust, W. J., Miller, B. L., Rankin, K. P., Rabinovici, G. D., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz4069 · Cited by 105
Self-citationGuo, T., Korman, D., Baker, S. L., Landau, S. M., & Jagust, W. J. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.06.029 · Cited by 103
Self-citationContribution of mixed pathology to medial temporal lobe atrophy in Alzheimer's disease
de Florès, R., Wisse, L. E. M., Das, S. R., Xie, L., McMillan, C. T., Trojanowski, J. Q., Robinson, J. L., Grossman, M., Lee, E. B., Irwin, D. J., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12079 · Cited by 103
Pokorny, T., Duerler, P., Seifritz, E., Vollenweider, F. X., & Preller, K. H. (2019) · Psychological Medicine · doi:10.1017/s0033291719002393 · Cited by 105
García-Morales, V., González-Acedo, A., Melguizo-Rodríguez, L., Pardo-Moreno, T., Costela-Ruiz, V. J., Montiel-Troya, M., & Ramos-Rodríguez, J. J. (2021) · Biomedicines · doi:10.3390/biomedicines9121910 · Cited by 104
New perspectives on the basal forebrain cholinergic system in Alzheimer’s disease
Berry, A. S., & Harrison, T. M. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105192 · Cited by 102
Local Sleep and Alzheimer’s Disease Pathophysiology
Mander, B. A. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.525970 · Cited by 97
Park, J., Hong, J., Lee, S., Ji, H. D., Jung, J.-A., Yoon, K.-W., Lee, J.-I., Won, K. S., Song, B., & Kim, H. W. (2019) · Scientific Reports · doi:10.1038/s41598-019-50681-4 · Cited by 96
Hossain, M. S., & Hussain, M. H. (2025) · Pharmacology Research & Perspectives · doi:10.1002/prp2.70131 · Cited by 105
Three-dimensional mapping of neurofibrillary tangle burden in the human medial temporal lobe
Yushkevich, P. A., Muñoz, M., Martin, M. M. I. D. O., Ittyerah, R., Lim, S., Ravikumar, S., Bedard, M. L., Pickup, S., Liu, W., Wang, J., et al. (2021) · Brain · doi:10.1093/brain/awab262 · Cited by 96
Gallego-Rudolf, J., Wiesman, A. I., Binette, A. P., Villeneuve, S., & Baillet, S. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01763-8 · Cited by 109
Sala, A., & Perani, D. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00617 · Cited by 88
Nobukawa, S., Yamanishi, T., Kasakawa, S., Nishimura, H., Kikuchi, M., & Takahashi, T. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00255 · Cited by 89
Is tau in the absence of amyloid on the Alzheimer’s continuum?: A study of discordant PET positivity
Weigand, A. J., Bangen, K. J., Thomas, K. R., Delano‐Wood, L., Gilbert, P. E., Brickman, A. M., Bondi, M. W., & Initiative, A. D. N. (2019) · Brain Communications · doi:10.1093/braincomms/fcz046 · Cited by 93
Yulug, B., Altay, O., Li, X., Hanoglu, L., Cankaya, S., Lam, S., Velioglu, H. A., Yang, H., Coskun, E., Idil, E., et al. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00336-2 · Cited by 79
Tuena, C., Mancuso, V., Stramba-Badiale, C., Pedroli, E., Stramba‐Badiale, M., Riva, G., & Repetto, C. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-201017 · Cited by 85
Sang, Z., Wang, K., Shi, J., Liu, W., Cheng, X., Zhu, G., Wang, Y., Zhao, Y., Qiao, Z., Wu, A., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112180 · Cited by 77
Modelling prognostic trajectories of cognitive decline due to Alzheimer's disease
Giorgio, J., Landau, S. M., Jagust, W. J., Peter Tiňo, B., & Kourtzi, Z. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102199 · Cited by 79
Self-citationComparing tau status determined via plasma pTau181, pTau231 and [18F]MK6240 tau-PET
Tissot, C., Therriault, J., Kunach, P., Benedet, A. L., Pascoal, T. A., Ashton, N. J., Karikari, T. K., Servaes, S., Lussier, F. Z., Chamoun, M., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103837 · Cited by 78
Huang, D., Chen, L., Ji, Q., Xiang, Y., Zhou, Q., Chen, K., Zhang, X., Zou, F., Zhang, X., Zhao, Z., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102990 · Cited by 78
Kazim, S. F., Sharma, A., Saroja, S. R., Seo, J. H., Larson, C. S., Ramakrishnan, A., Wang, M., Blitzer, R. D., Shen, L., Peña, C. J., et al. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.02.973 · Cited by 75
Endozepines and their receptors: Structure, functions and pathophysiological significance
Tonon, M., Vaudry, H., Chuquet, J., Guillebaud, F., Fan, J., Masmoudi‐Kouki, O., Vaudry, D., Lanfray, D., Morin, F., Prévot, V., et al. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.06.008 · Cited by 80
Amidst an amygdala renaissance in Alzheimer’s disease
Stouffer, K. M., Grande, X., Düzel, E., Johansson, M., Creese, B., Witter, M. P., Miller, M. I., Wisse, L. E. M., & Berron, D. (2023) · Brain · doi:10.1093/brain/awad411 · Cited by 72
Białecka-Dębek, A., Granda, D., Szmidt, M. K., & Zielińska, D. (2021) · Nutrients · doi:10.3390/nu13082514 · Cited by 68
Regional Precuneus Cortical Hyperexcitability in Alzheimer's Disease Patients
Casula, E. P., Borghi, I., Maiella, M., Pellicciari, M. C., Bonnı̀, S., Mencarelli, L., Assogna, M., D’Acunto, A., Lorenzo, F. D., Spampinato, D. A., et al. (2022) · Annals of Neurology · doi:10.1002/ana.26514 · Cited by 70
Neuroinflammation PET imaging of the translocator protein (TSPO) in Alzheimer's disease: An update
Gouilly, D., Saint‐Aubert, L., Ribeiro, M. J., Salabert, A., Tauber, C., Péran, P., Arlicot, N., Pariente, J., & Payoux, P. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15613 · Cited by 70
rPOP: Robust PET-only processing of community acquired heterogeneous amyloid-PET data
Iaccarino, L., Joie, R. L., Koeppe, R. A., Siegel, B. A., Hillner, B. E., Gatsonis, C. A., Whitmer, R. A., Carrillo, M. C., Apgar, C., Camacho, M. R., et al. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2021.118775 · Cited by 64
Tissot, C., Therriault, J., Pascoal, T. A., Chamoun, M., Lussier, F. Z., Savard, M., Mathotaarachchi, S. S., Benedet, A. L., Thomas, E. M., Parsons, M., et al. (2021) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12154 · Cited by 63
The complex pathway between amyloid β and cognition: implications for therapy
Jagust, W. J., Teunissen, C. E., & DeCarli, C. S. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(23)00128-x · Cited by 67
Self-citationDahl, M. J., Kulesza, A., Werkle‐Bergner, M., & Mather, M. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105358 · Cited by 67
Mechanisms of Intranasal Deferoxamine in Neurodegenerative and Neurovascular Disease
Kosyakovsky, J., Fine, J. M., Frey, W. H., & Hanson, L. R. (2021) · Pharmaceuticals · doi:10.3390/ph14020095 · Cited by 67
Mander, B. A., Dave, A., Lui, K. K., Sprecher, K. E., Berisha, D. E., Chappel-Farley, M. G., Chen, I. Y., Riedner, B. A., Heston, M. B., Suridjan, I., et al. (2022) · SLEEP · doi:10.1093/sleep/zsac135 · Cited by 62
Zinc in Cognitive Impairment and Aging
Sun, R., Wang, J., Feng, J., & Cao, B. (2022) · Biomolecules · doi:10.3390/biom12071000 · Cited by 70
A data-driven study of Alzheimer's disease related amyloid and tau pathology progression
Aksman, L., Oxtoby, N. P., Scelsi, M. A., Wijeratne, P. A., Young, A. L., Alves, I. L., Collij, L. E., Vogel, J. W., Barkhof, F., Alexander, D. C., et al. (2023) · Brain · doi:10.1093/brain/awad232 · Cited by 69
Cognitive interventions for memory and psychological well-being in aging and dementias
Dinius, C. J., Pocknell, C. E., Caffrey, M. P., & Roche, R. A. P. (2023) · Frontiers in Psychology · doi:10.3389/fpsyg.2023.1070012 · Cited by 62
Iaccarino, L., Joie, R. L., Edwards, L., Strom, A., Schonhaut, D. R., Ossenkoppele, R., Pham, J. Q., Mellinger, T. J., Janabi, M., Baker, S. L., et al. (2020) · Cerebral Cortex · doi:10.1093/cercor/bhaa184 · Cited by 56
Self-citationLi, Y., Zhu, K., Li, N., Wang, X., Xiao, X., Li, L., Li, L., He, Y., Zhang, J., Wo, J., et al. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00859-8 · Cited by 51
Causal structural covariance network revealing atrophy progression in Alzheimer's disease continuum
Zhao, Q., Chen, F., Lu, J., Lv, P., Li, W., Liang, X., Wang, M., Wang, Z., Zhang, X., Zhang, B., et al. (2021) · Human Brain Mapping · doi:10.1002/hbm.25531 · Cited by 52
Shi, Z., Cao, X., Hu, J., Jiang, L., Mei, X., Zheng, H., Chen, Y., Wang, M., Cao, J., Li, W., et al. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109824 · Cited by 55
Vickery, S., Hopkins, W. D., Sherwood, C. C., Schapiro, S. J., Latzman, R. D., Caspers, S., Gaser, C., Eickhoff, S. B., Dahnke, R., & Hoffstaedter, F. (2020) · eLife · doi:10.7554/elife.60136 · Cited by 54
Winer, J. R., Morehouse, A. B., Fenton, L. E., Harrison, T. M., Ayangma, L., Reed, M. E., Kumar, S., Baker, S. L., Jagust, W. J., & Walker, M. P. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.0353-21.2021 · Cited by 59
Self-citationAutomatic Early Diagnosis of Alzheimer’s Disease Using 3D Deep Ensemble Approach
Gamal, A., Elattar, M., & Selim, S. (2022) · IEEE Access · doi:10.1109/access.2022.3218621 · Cited by 56
The chemistry of gut microbiome in health and diseases
Lau, A., Tan, L. T., Mutalib, N. A., Wong, S. H., Letchumanan, V., & Lee, L. (2021) · Progress In Microbes & Molecular Biology · doi:10.36877/pmmb.a0000175 · Cited by 55
Tipping points in neurodegeneration
Simons, M., Levin, J., & Dichgans, M. (2023) · Neuron · doi:10.1016/j.neuron.2023.05.031 · Cited by 52
Timmers, T., Ossenkoppele, R., Wolters, E. E., Verfaillie, S. C. J., Visser, D., Golla, S. S. V., Barkhof, F., Scheltens, P., Boellaard, R., van der Flier, W. M., et al. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0510-3 · Cited by 55
Dou, X., Yao, H., Feng, F., Wang, P., Zhou, B., Jin, D., Yang, Z., Li, J., Zhao, C., Wang, L., et al. (2020) · Cortex · doi:10.1016/j.cortex.2020.03.032 · Cited by 51
The P2X7 receptor: a new therapeutic target in Alzheimer’s disease
Illés, P., Rubini, P., Huang, L., & Tang, Y. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1575811 · Cited by 50
McFarland, K. N., & Chakrabarty, P. (2022) · Neurotherapeutics · doi:10.1007/s13311-021-01179-3 · Cited by 48
Transcriptional Networks of Microglia in Alzheimer’s Disease and Insights into Pathogenesis
Chew, G., & Petretto, E. G. (2019) · Genes · doi:10.3390/genes10100798 · Cited by 46
Metadata
- Authors
- Jagust, W.
- Affiliations
- Lawrence Berkeley National Laboratory (US)
- Corresponding author
- Jagust, William
- ORCID
- Jagust, William
- Venue
- Nature Reviews Neuroscience
- Published
- 2018-09-28
- Volume
- 19
- Issue
- 11
- Pages
- 687-700
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- PMC
- PMC7032048
- OpenAlex
- W2894357926
- Cited by
- 604
- References
- 213
- Citations by year
- 2026: 73 · 2025: 85 · 2024: 89 · 2023: 94 · 2022: 76 · 2021: 85 · 2020: 58 · 2019: 40 · 2018: 2
- FWCI
- 7.13
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (R01AG045611, R01AG062542, P01AG019724, R01AG034570)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, amyloid-beta, tau protein, neurodegeneration, brain atrophy, hypometabolism, medial parietal cortex, medial temporal lobe, cognitive decline, dementia, disease progression
- MeSH terms
- Aging, Alzheimer Disease, Brain, Humans, Amyloid beta-Peptides, tau Proteins, Disease Progression, Multimodal Imaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
